BG104682A - Течна фармацевтична форма, съдържаща зотепин - Google Patents

Течна фармацевтична форма, съдържаща зотепин

Info

Publication number: BG104682A
Authority: BG; Bulgaria
Prior art keywords: liquid pharmaceutical; pharmaceutical form; zotinein; form containing; liquid
Prior art date: 1998-02-07

Application number

BG104682A

Other languages

Bulgarian (bg)

English (en)

Inventor

Ann DYER

Alan Smith

Original Assignee

Knoll Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-07

Filing date

2000-08-09

Publication date

2001-05-31

2000-08-09 Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft

2001-05-31 Publication of BG104682A publication Critical patent/BG104682A/xx

Links

239000007788 liquid Substances 0.000 title abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 abstract 1
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 abstract 1
QISOBCMNUJQOJU-UHFFFAOYSA-N 4-bromo-1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1NN=CC=1Br QISOBCMNUJQOJU-UHFFFAOYSA-N 0.000 abstract 1
PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 abstract 1
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 abstract 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 abstract 1
239000003085 diluting agent Substances 0.000 abstract 1
BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 abstract 1
239000004310 lactic acid Substances 0.000 abstract 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 1
235000014655 lactic acid Nutrition 0.000 abstract 1
239000001630 malic acid Substances 0.000 abstract 1
235000011090 malic acid Nutrition 0.000 abstract 1
150000007524 organic acids Chemical class 0.000 abstract 1
239000004334 sorbic acid Substances 0.000 abstract 1
235000010199 sorbic acid Nutrition 0.000 abstract 1
229940075582 sorbic acid Drugs 0.000 abstract 1
239000011975 tartaric acid Substances 0.000 abstract 1
235000002906 tartaric acid Nutrition 0.000 abstract 1
HDOZVRUNCMBHFH-UHFFFAOYSA-N zotepine Chemical compound CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12 HDOZVRUNCMBHFH-UHFFFAOYSA-N 0.000 abstract 1
229960004496 zotepine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

BG104682A 1998-02-07 2000-08-09 Течна фармацевтична форма, съдържаща зотепин BG104682A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9802617.2A GB9802617D0 (en)	1998-02-07	1998-02-07	Pharmaceutical formulation
PCT/EP1999/000533 WO1999039709A1 (en)	1998-02-07	1999-01-27	Liquid pharmaceutical formulation containing zotepine

Publications (1)

Publication Number	Publication Date
BG104682A true BG104682A (bg)	2001-05-31

Family

ID=10826622

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG104682A BG104682A (bg)	1998-02-07	2000-08-09	Течна фармацевтична форма, съдържаща зотепин

Country Status (24)

Country	Link
US (1)	US6239165B1 (de)
EP (1)	EP1054666B1 (de)
JP (1)	JP2002502818A (de)
KR (1)	KR20010040717A (de)
AR (1)	AR018062A1 (de)
AT (1)	ATE227988T1 (de)
AU (1)	AU2720099A (de)
BG (1)	BG104682A (de)
BR (1)	BR9907644A (de)
CA (1)	CA2320475A1 (de)
CO (1)	CO4970815A1 (de)
CZ (1)	CZ291975B6 (de)
DE (1)	DE69904021T2 (de)
DK (1)	DK1054666T3 (de)
ES (1)	ES2188135T3 (de)
GB (1)	GB9802617D0 (de)
HR (1)	HRP20000579A2 (de)
HU (1)	HUP0100769A3 (de)
PL (1)	PL342213A1 (de)
PT (1)	PT1054666E (de)
SK (1)	SK11472000A3 (de)
TR (1)	TR200002288T2 (de)
WO (1)	WO1999039709A1 (de)
ZA (1)	ZA99918B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006032427A1 (de) *	2006-07-13	2008-01-17	Neuraxpharm Arzneimittel Gmbh U. Co. Kg	Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) *	2006-07-13	2008-01-17	Neuraxpharm Arzneimittel Gmbh U. Co. Kg	Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1247067A (en)	1968-02-16	1971-09-22	Fujisawa Pharmaceutical Co	Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) *	1975-02-06	1976-08-10		Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja)	1981-09-24	1983-03-28	Fujisawa Pharmaceut Co Ltd	血清尿酸値低下剤
JPH07116039B2 (ja) *	1988-01-11	1995-12-13	オール薬品工業株式会社	安定な塩酸トリメトキノール内用液剤
AR245888A1 (es) *	1989-01-23	1994-03-30	Merrell Pharma Inc	Procedimiento para la preparacion de una composicion farmaceutica liquida de derivados de piperidinoalcanol.
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
JPH0827034A (ja) *	1994-07-14	1996-01-30	Nikken Chem Co Ltd	エリスリトール含有内用液剤
IL117612A0 (en)	1995-03-24	1996-07-23	Lilly Co Eli	Granule formulation for olanzapine
GB9526264D0 (en)	1995-12-21	1996-02-21	Knoll Ag	Medical treatment
JPH09286723A (ja) *	1996-04-19	1997-11-04	Takeda Chem Ind Ltd	改善された経口液剤

1998
- 1998-02-07 GB GBGB9802617.2A patent/GB9802617D0/en not_active Ceased
1999
- 1999-01-27 SK SK1147-2000A patent/SK11472000A3/sk unknown
- 1999-01-27 PL PL99342213A patent/PL342213A1/xx unknown
- 1999-01-27 DE DE69904021T patent/DE69904021T2/de not_active Expired - Fee Related
- 1999-01-27 AT AT99907436T patent/ATE227988T1/de not_active IP Right Cessation
- 1999-01-27 US US09/600,980 patent/US6239165B1/en not_active Expired - Fee Related
- 1999-01-27 HU HU0100769A patent/HUP0100769A3/hu unknown
- 1999-01-27 CA CA002320475A patent/CA2320475A1/en not_active Abandoned
- 1999-01-27 WO PCT/EP1999/000533 patent/WO1999039709A1/en not_active Ceased
- 1999-01-27 TR TR2000/02288T patent/TR200002288T2/xx unknown
- 1999-01-27 CZ CZ20002846A patent/CZ291975B6/cs not_active IP Right Cessation
- 1999-01-27 KR KR1020007008599A patent/KR20010040717A/ko not_active Withdrawn
- 1999-01-27 HR HR20000579A patent/HRP20000579A2/hr not_active Application Discontinuation
- 1999-01-27 ES ES99907436T patent/ES2188135T3/es not_active Expired - Lifetime
- 1999-01-27 DK DK99907436T patent/DK1054666T3/da active
- 1999-01-27 PT PT99907436T patent/PT1054666E/pt unknown
- 1999-01-27 JP JP2000530208A patent/JP2002502818A/ja active Pending
- 1999-01-27 AU AU27200/99A patent/AU2720099A/en not_active Abandoned
- 1999-01-27 EP EP99907436A patent/EP1054666B1/de not_active Expired - Lifetime
- 1999-01-27 BR BR9907644-6A patent/BR9907644A/pt not_active IP Right Cessation
- 1999-02-04 AR ARP990100471A patent/AR018062A1/es not_active Application Discontinuation
- 1999-02-04 CO CO99006457A patent/CO4970815A1/es unknown
- 1999-02-05 ZA ZA9900918A patent/ZA99918B/xx unknown
2000
- 2000-08-09 BG BG104682A patent/BG104682A/xx unknown

Also Published As

Publication number	Publication date
PL342213A1 (en)	2001-05-21
ES2188135T3 (es)	2003-06-16
HUP0100769A2 (hu)	2001-12-28
DK1054666T3 (da)	2003-03-17
HK1033088A1 (en)	2001-08-17
JP2002502818A (ja)	2002-01-29
KR20010040717A (ko)	2001-05-15
AR018062A1 (es)	2001-10-31
ATE227988T1 (de)	2002-12-15
WO1999039709A1 (en)	1999-08-12
CO4970815A1 (es)	2000-11-07
AU2720099A (en)	1999-08-23
US6239165B1 (en)	2001-05-29
BR9907644A (pt)	2000-11-14
EP1054666A1 (de)	2000-11-29
HUP0100769A3 (en)	2002-04-29
DE69904021D1 (de)	2003-01-02
PT1054666E (pt)	2003-03-31
CZ20002846A3 (cs)	2000-12-13
SK11472000A3 (sk)	2001-08-06
CA2320475A1 (en)	1999-08-12
ZA99918B (en)	2000-08-07
CZ291975B6 (cs)	2003-06-18
HRP20000579A2 (en)	2001-04-30
GB9802617D0 (en)	1998-04-01
TR200002288T2 (tr)	2000-12-21
EP1054666B1 (de)	2002-11-20
DE69904021T2 (de)	2003-04-30

Publication	Publication Date	Title
CA2402431A1 (en)	2001-09-20	1,2,3,4-tetrahydroisoquinoline derivatives
HUP0203836A3 (en)	2005-03-29	1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
CO5580776A2 (es)	2005-11-30	Formulacion farmaceutica estable en solucion de oxaliplatino
WO2003045878A3 (en)	2004-03-04	2,w-diaminocarboxylic acid compounds
CA2129995A1 (en)	1993-08-19	Piperidinyl thiacyclic derivatives
CA2361402A1 (en)	2001-03-15	Bis-sulfonamides
CA2157146A1 (en)	1996-03-01	Heterocyclyl-benzoylguanidines
DE69941255D1 (de)	2009-09-24	Verbindungen mit wachstumshormon freisetzenden eigenschaften
DE60118956D1 (de)	2006-05-24	Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
MA21531A1 (fr)	1989-12-31	Compositions antifougique symergique contenant de l'imazalil et du propieon azole, procede pour sa preparation et procede de lutte contre les champignons l'utilisant .
DE60204755D1 (de)	2005-07-28	"3,7-diazabicyclo(3.3.0)octane und deren verwendung bei der behandlung von herzrhythmusstörungen"
IL137794A0 (en)	2001-10-31	Streptogramin derivatives, preparation method and compositions containing same
CA2359491A1 (en)	2000-08-24	Mixture of plant treatment compositions with waxes, their preparation, and their use
WO2002008222A3 (en)	2002-06-13	HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS
WO2002024665A8 (en)	2002-06-06	Arylalkane-sulfonamides having endothelin-antagonist activity
PT1427417E (pt)	2008-06-02	Derivados de 6, 7-di-hidroxitetra-hidroisoquinolina substituída em 3 para utilização como agentes antibacterianos
MXPA03001455A (es)	2004-05-04	Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa.
WO2001009122A3 (en)	2001-06-28	Serotonergic benzofurans
WO2003048342A3 (en)	2004-06-10	Liquid yeast compositions
ES2188135T3 (es)	2003-06-16	Formulacion farmaceutica liquida que contiene zotepina.
JP2001354553A5 (de)	2004-12-09
DE69312915D1 (de)	1997-09-11	Psyllium enthaltende zusammenstellungen für getränke ohne geschmackstoffe
GEP20063973B (en)	2006-11-27	Streptogramin derivatives, production thereof and compositions containing them
JPS5743669A (en)	1982-03-11	Food having improved shelf stability
RU2001134864A (ru)	2003-08-10	Композиция с рострегулирующей активностью